FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Leonard Thomas J 		2. Issuer Name and Ticker or Trading Symbol

CAREFUSION Corp [ CFN ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
President, Medical Systems
(Last)          (First)          (Middle)

C/O CAREFUSION CORPORATION, 3750 TORREY VIEW COURT 		3. Date of Earliest Transaction (MM/DD/YYYY)

9/19/2014
(Street)

SAN DIEGO,, CA 92130
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   9/19/2014     M (1)    4141   A $20.71   44274   D  
 
Common Stock   9/19/2014     M (1)    12459   A $22.59   57733   D  
 
Common Stock   9/19/2014     S (1)    16600   D $47.01   (2) 40133   D  
 

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (right to buy)   $20.71   9/19/2014     M   (1)       4141      (3) 9/15/2016   Common Stock   4141   $0   (4) 0   D  
 
Stock Options (right to buy)   $22.59   9/19/2014     M   (1)       12459      (3) 8/16/2017   Common Stock   12459   $0   (4) 57563   D  
 

Explanation of Responses:
( 1)  The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
( 2)  Represents the weighted average price of shares sold in multiple same-day transactions at prices ranging from $47.00 to $47.01 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
( 3)  This award was granted pursuant to the CareFusion Corporation 2009 Long-Term Incentive Plan. These stock options are now fully exercisable.
( 4)  Granted without payment by grantee.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Leonard Thomas J
C/O CAREFUSION CORPORATION
3750 TORREY VIEW COURT
SAN DIEGO,, CA 92130

President, Medical Systems

Signatures
Nathaniel Sisitsky, Attorney-in-Fact 9/22/2014
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.